325 related articles for article (PubMed ID: 24115128)
1. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.
Sutti S; Jindal A; Locatelli I; Vacchiano M; Gigliotti L; Bozzola C; Albano E
Hepatology; 2014 Mar; 59(3):886-97. PubMed ID: 24115128
[TBL] [Abstract][Full Text] [Related]
2. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
3. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.
Maina V; Sutti S; Locatelli I; Vidali M; Mombello C; Bozzola C; Albano E
Clin Sci (Lond); 2012 Jun; 122(11):545-53. PubMed ID: 22142284
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
6. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
[TBL] [Abstract][Full Text] [Related]
7. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
[TBL] [Abstract][Full Text] [Related]
8. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
[TBL] [Abstract][Full Text] [Related]
9. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
[TBL] [Abstract][Full Text] [Related]
10. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 Jan; 208(1):74-81. PubMed ID: 16261527
[TBL] [Abstract][Full Text] [Related]
12. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
13. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
14. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.
Li Z; Soloski MJ; Diehl AM
Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis.
Aghazadeh S; Amini R; Yazdanparast R; Ghaffari SH
Exp Toxicol Pathol; 2011 Sep; 63(6):569-74. PubMed ID: 20471811
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.
Liu Y; Song H; Wang L; Xu H; Shu X; Zhang L; Li Y; Li D; Ji G
J Transl Med; 2014 Nov; 12():315. PubMed ID: 25406833
[TBL] [Abstract][Full Text] [Related]
18. Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis.
Chung MY; Yeung SF; Park HJ; Volek JS; Bruno RS
J Nutr Biochem; 2010 Dec; 21(12):1200-6. PubMed ID: 20138495
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.
Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM
Hepatology; 2004 Aug; 40(2):434-41. PubMed ID: 15368448
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.
Syn WK; Oo YH; Pereira TA; Karaca GF; Jung Y; Omenetti A; Witek RP; Choi SS; Guy CD; Fearing CM; Teaberry V; Pereira FE; Adams DH; Diehl AM
Hepatology; 2010 Jun; 51(6):1998-2007. PubMed ID: 20512988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
